Eris Lifesciences Limited has informed the Exchange regarding Board meeting held on November 12, 2025.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences Limited has notified the NSE about a board meeting that took place on November 12, 2025. The filing is a procedural intimation required by listing rules whenever a company's board meets to consider key matters. No specific agenda items, decisions, financial results, or approvals are mentioned in this particular disclosure. Investors will need to await the company's detailed outcome announcement to understand what was discussed or approved.
On its own, this intimation is a routine compliance filing and is unlikely to move the stock price. Any meaningful impact would depend on what the board actually decided, which will come out in a separate outcome filing.